The short version of electrospray ionisation fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-05-21 and is reviewed periodically as new material appears.
Human data remain limited and come mainly from small, short-term studies conducted decades ago. The peptide has not received approval as a medicine from major regulators, so current availability is largely as a research chemical. Reported effects on growth hormone pulsatility, appetite, and body composition should be read as preliminary, since few independent groups have replicated the original findings. Analytical characterization of research-grade material varies between suppliers, which complicates comparison across studies. Regulatory status also differs by country, and some jurisdictions classify it as a prescription-only or otherwise restricted item.
Ipamorelin is a synthetic pentapeptide that belongs to the growth hormone secretagogue class. It acts as an agonist at the ghrelin receptor, also called the growth hormone secretagogue receptor type 1a. The compound was designed in the 1990s during a search for agents that release growth hormone with fewer off-target hormonal effects than earlier secretagogues. It appears in the research literature under several sequence-based names. Material supplied for laboratory work is normally a lyophilized solid, and it is not marketed as an approved therapeutic in major jurisdictions.
The lyophilised solid is normally held at -20 °C or colder, shielded from light and moisture. Stability in that state is measured in years, although shelf life depends on residual water content and the container seal. Once dissolved, the peptide is more fragile: aqueous solutions are commonly kept at 2-8 °C and used within days to weeks, and repeated freeze-thaw cycling is avoided. Strongly acidic or basic conditions accelerate hydrolysis, and prolonged exposure to them can strip the terminal amide.
Purity assessment for this peptide relies mainly on reversed-phase high-performance liquid chromatography. A C18 column with a water-acetonitrile gradient containing trifluoroacetic acid separates the target from truncated sequences and oxidation products. Detection near 214 nm exploits the amide backbone, while the aromatic side chains allow additional monitoring close to 280 nm. Reported purity values depend on the method, so a certificate of analysis carries weight only when gradient, column and integration parameters are given.
Mass spectrometry confirms identity and reveals structural deviations that chromatography alone can miss. Positive-mode electrospray ionisation generally yields multiply charged ions whose deconvoluted mass is checked against the theoretical value. Amino acid analysis, and enzymatic digestion with subsequent fragment mapping, provide independent confirmation of sequence and of the terminal amide. Analysts take care to separate the target from deletion sequences, which may differ by one residue and therefore by only a small mass increment.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C38H49N9O5 | Value for the free base |
| Molar mass | 711.9 g/mol | Calculated from the formula |
| Appearance | White to off-white powder | Typical lyophilized form |
| Mechanism class | Ghrelin receptor agonist | Also described as a secretagogue |
| Half-life | About 2 hours | Reported for human circulation |
Analytical confirmation relies on reversed-phase high-performance liquid chromatography, often coupled to mass spectrometry for identity and purity assessment. Mass spectrometry distinguishes the intact molecule from truncation products and from oxidation or deamidation variants that share similar chromatographic retention. Immunoassays appear in some biological studies but can cross-react with related peptides, so they are weaker tools for identity work. Reported purity figures depend heavily on the gradient, detector, and integration method used, which complicates direct comparison between laboratories.
Research quantities of ipamorelin are typically distributed as a white to off-white lyophilized powder. The solid dissolves readily in water and in aqueous buffers, and stock solutions are commonly prepared in sterile water or a mildly acidic diluent. Adsorption to plastic and glass surfaces can reduce the concentration of very dilute solutions, so containers and transfer steps deserve attention when accurate concentrations matter. Reconstituted material is generally used promptly rather than held for extended periods.
Storage recommendations for the dry solid center on low temperature and low moisture, most often -20 °C in a sealed, desiccated container protected from light. Solutions are less stable than the powder and are usually kept cold and used within a short window. Freeze-thaw cycling is a recognized source of loss, and aliquoting before freezing is a standard precaution. These practices derive from general peptide handling principles rather than from a single published stability trial, so exact shelf lives should be treated as approximate.
== Ligands and potential ligand-based disease related activities == The functions of FPR3 and the few ligands which activate it have not been fully clarified. Despite its homology to FPR1, FPR3 is unresponsive to many FPR1-stimulating formyl peptides including FMLP. However, fMMYALF, a N-formyl hexapeptide derived from the mitochondrial protein, NADH dehydrogenase subunit 6, is a weak agonist for FPR3 but >100-fold more potent in stimulating FPR1 and FPR2. F2L is a naturally occurring acylated peptide derived from the N-terminal sequence of heme-binding protein 1 by cathepsin D cleavage that potently stimulates chemotaxis through FPR3 in monocytes and monocyte-derived dendritic cells. F2L thereby may be a pro-inflammatory stimulus for FPR3. Similar to FPR2 (see FPR2 section), FPR3 is activated by humanin and thereby may be involved in inhibiting the inflammation occurring in and perhaps contributing to Alzheimer's disease.
No candidate from PEJUANG or Gerakan Tanah Air secured a seat. He later said that his party's plans "had to be dropped" and he would shift his focus to writing about Malaysian history. In February 2023, Mahathir and 13 other members of PEJUANG (leaving his own son as the sole leader of that party) left the party and joined Parti Bumiputera Perkasa Malaysia (Putra). Later in 2023, Mahathir began promoting a "Malay Proclamation", aimed at uniting Malays. He met with PAS and PN leaders to garner support for the 12-point document listing political, economic and social issues. Mahathir was questioned by police over this campaign under the Malaysian Penal Code, for carrying out "activities that undermine parliamentary democracy". Mahathir also left GTA, criticising the coalition for its poor performance in the election. He supported Perikatan Nasional, the coalition that had ousted him in 2020, in six state elections and was named its "unofficial adviser" for the four state governments under its control. On 31 August 2024, Mahathir attended the Merdeka Day celebration in Putrajaya in his personal capacity, as he was not officially invited by the government. His presence at the event, where he was warmly received by the crowd, sparked public debate. Prominent academic Chandra Muzaffar criticised the government's decision, describing it as a breach of Malaysian etiquette and values, particularly given Mahathir's status as the country's longest-serving prime minister.
=== Pharmacodynamics === Diazoxide acts as a ATP-sensitive potassium channel (KATP) opener. It has been found to act as a positive allosteric modulator of the ionotropic glutamate AMPA and kainate receptors.
== History == Vosilasarm was developed by Radius Health in 2010. It was first described in the literature in 2011 in a paper detailing its design, synthesis, and preclinical characterization in vitro and in rats and monkeys. It was stated in this paper that phase 1 clinical studies of vosilasarm for treatment of severe weight loss due to cancer cachexia were being prepared. However, these studies were never completed or published and development for this indication was discontinued. Subsequently, vosilasarm was repurposed for the treatment of breast cancer.
Arthur 'Blaine' Bowman (born 1946 in Ogden, Utah, USA) is a leading proponent of ion chromatography, who has served variously as chairman, president, chief executive officer, and director of Dionex Corporation, a manufacturer of analytical instruments. Bowman received the 2015 Pittcon Heritage Award in recognition of his contributions to the field of ion chromatography. Arthur 'Blaine' Bowman was born in 1946 in Ogden, Utah, US. Around age 10, his family moved to Southern California, where he grew up. Bowman attended Brigham Young University in Provo, Utah in the physics program. As an undergraduate, he worked in the summer as an engineer at McDonnell Douglas, testing modules for the Apollo rocket. Bowman received his B.S. in physics in 1970. Next, Bowman worked as a product engineer at Motorola's Semiconductor Products Division in Phoenix, Arizona, where he became interested in business. He attended Stanford University's school of business from 1971 to 1973, receiving his M.B.A. in 1973. He then joined McKinsey & Company as a management consultant.
Sources: en.wikipedia.org
mRNA display is a method to identify peptides which bind to a particular molecular target. The process utilizes two main components: an immobilized target and a peptide library in which each peptide is covalently linked to an mRNA:cDNA which encodes it. The immobilized target is mixed with the library in a binding step, then those peptide-mRNA:cDNA fusions which do not bind are washed away. The resulting mixture, which is enriched in peptide-mRNA:cDNA fusions that bind, is then amplified via a polymerase chain reaction (PCR). A new peptide library enriched in binding sequences is prepared from this cDNA, and the process is repeated for several rounds. The result is the isolation of nucleotides with sequences that encode peptides with high affinity for the target.
A significant amount of zirconium is formed by the fission process; some of this consists of short-lived radionuclides (95Zr and 97Zr which decay to molybdenum), while almost 10% of the fission products mixture after years of decay consists of five stable or nearly stable isotopes of zirconium plus 93Zr with a halflife of 1.53 million years which is one of the 7 major long-lived fission products. Zirconium is commonly used in cladding of fuel rods due to its low neutron cross section. However, a small share of this zirconium does capture neutrons and contributes to the overall inventory of radioactive zirconium isotopes. Zircalloy cladding is not commonly reused and neither is fission product zirconium, which could be used in cladding as its relatively weak radioactivity would be of no major concern inside a nuclear reactor. Despite its high yield and long live, Zr-93 is generally not deemed to be of major concern as it is not chemically mobile and emits little radiation. In PUREX plants the zirconium (regardless of source or isotope) sometimes forms a third phase which can be a disturbance in the plant. The third phase is the term in solvent extraction given to a third layer (such as foam and/or emulsion) which forms from the two layers in the solvent extraction process. The zirconium forms the third phase by forming small particles which stabilise the emulsion which is the third phase. Zirconium-90 mostly forms by successive beta decays out of strontium-90.
Computational neuroscientists show that people with higher intelligence scores in HCP cognitive tests took more time to solve difficult problems and that their higher synchrony between brain areas allowed for better integration of evidence (or progress) from preceding working memory sub-problem processing. Reducing synchrony in "avatar" simulations, that were adjusted and tuned towards personalization, "led decision-making circuits to quickly jump to conclusions". Their codified results may be useful for an understanding of cognition to replicate or imitate in bio-inspired computing. Researchers report trends in reasons for HPV vaccine hesitancy during 2010–20. 24 May Scientists show how gene 'FAAH'-related disruption via genetic or epigenome editing can enable pain insensitivity (see also 10 March 2021). Their analyses, mainly about long non-coding RNA 'FAAH-OUT', following from decade-long study of a woman who can't feel pain or anxiety, could also enable novel therapeutic developments against other neurological problems. One of the first empirical studies on what real users are shown during their typical use of popular Web search engines interprets its results to show that choices for unreliable news sources for their queries are driven primarily by users' own choices and less by the engine's algorithms. The Web scientists link their findings to the concept of filter bubbles which emphasizes the role of design- and personalization algorithms.
== Metabolism/Biotransformation == Quisqualic acid enters the body through different routes, such as ingestion, inhalation, or injection. The ADME (absorption, distribution, metabolism and excretion) process has been studied by means of various animal models in the laboratory. Absorption: quisqualic acid is a small and lipophilic molecule, thus is expected to be rapid. It is predicted to be absorbed in the human intestine and from then it circulates to the blood brain barrier. Analysis of amino acid transport systems is complex by the presence of multiple transporters with overlapping specificity. Since glutamate and quisqualic acid are similar, it is predicted that sodium/potassium transport in the gastrointestinal tract is the absorption site of the acid. Distribution: knowing the receptors it binds to, it can be readily predicted where the acid is present such as: hippocampus, basal ganglia, olfactory regions. Metabolism: quisqualic acid is thought to be metabolized in the liver by oxidative metabolism carried out by cytochrome P450 enzymes, Glutathione S-transferase (detoxifying agents). A study showed that the exposure to quisqualic acid revealed that P450, GST were involved. It is also confirmed by using admetSAR tool to evaluate chemical ADMET properties. Its metabolites are thought to be NMDA and quinolinic acid. Excretion: Mostly, as a rule of thumb, amino acids undergo transamination/deamination in the liver. Thus amino acids are converted into ammonia and keto acids, which are eventually excreted via the kidneys.
Ciskei ( səss-KY, siss-, -KAY, meaning on this side of [the river] Kei), officially the Republic of Ciskei (Xhosa: iRiphabliki yeCiskei), was a Bantustan for the Xhosa people, located in the southeast of South Africa. It covered an area of 7,700 square kilometres (3,000 sq mi), almost entirely surrounded by what was then the Cape Province, and possessed a small coastline along the shore of the Indian Ocean. Under South Africa's policy of apartheid, land was set aside for black peoples in self-governing territories. Ciskei was designated as one of two homelands, or "Bantustans", for Xhosa-speaking people. Xhosa people were forcibly resettled in the Ciskei and Transkei, the other Xhosa homeland. In contrast to the Transkei, which was largely contiguous and deeply rural, and governed by hereditary chiefs, the area that became the Ciskei had initially been made up of a patchwork of "reserves", interspersed with pockets of white-owned farms. In Ciskei, there were elected headmen and a relatively educated working-class populace, but there was a tendency of the region's black residents—who often worked in East London, Queenstown, and King Williams Town—to oppose traditional methods of control. These differences have been posited as the reason for two separate homelands for the Xhosa people being developed, as well as the later nominal independence of Ciskei from South Africa, than Transkei.
Sources: en.wikipedia.org
The lungs are especially sensitive and prone to damage, thus to avoid collateral damage to type I and type II pneumocytes, alveolar macrophages are kept in a quiescent state, producing little inflammatory cytokines and displaying little phagocytic activity, as evidenced by downregulated expression of the phagocytic receptor Macrophage 1 antigen (Mac-1). AMs actively suppress the induction of two of the immunity systems of the body: the adaptive immunity and humoral immunity. The adaptive immunity is suppressed through AM's effects on interstitial dendritic cells, B-cells and T-cells, as these cells are less selective of what they destroy, and often cause unnecessary damage to normal cells. To prevent uncontrolled inflammation in the lower respiratory tract, alveolar macrophages secrete nitric oxide, prostaglandins, interleukin-4 and -10(IL-4, IL-10), and transforming growth factor-β (TGF-β).
==== Protease inhibitors ==== Protease inhibitors are a class of compounds that inhibit the activity of proteases (enzymes responsible for cleaving peptide bonds in proteins). These inhibitors are crucial in various biological processes and therapeutic applications, as proteases play key roles in numerous physiological functions, including digestion, immune response, blood coagulation, and cell signaling. An extracellular cysteine protease inhibitor, ECPI-2, was purified from the culture medium of Chlorella sp. The inhibitor had an inhibitory effect against the proteolytic activity of papain, ficin, and chymopapain. ECPI-2 contains 33.6% carbohydrate residues that may be responsible for the stability of the enzyme under neutral or acidic conditions. These inhibitor proteins from Chlorella may be synthesized to protect cells from attacks by e.g., viruses or herbivores. Compared to organic compounds, peptide drugs are of relatively low toxicity to the human body. The development of peptide inhibitors as drugs is thus an attractive research topic in current medicinal chemistry. Protease inhibitors are attractive agents in the treatment of specific diseases; for instance, elastase is of critical importance in diseases like lung emphysema, which motivates further investigation on microalgal protease inhibitors as valuable lead-structures in pharmaceutical development.
One prominent case was the classification of ascolichen families by the structure of the ascus apex (the tip of the spore sac). Josef Hafellner (1984) reorganized many ascolichen families by ascus-apex staining (amyloid ring present vs. absent), treating that feature as primary. Later DNA work found several of those families to be polyphyletic: the ascus type had arisen independently in unrelated lineages. The results echoed Nylander's century-old warning against single-trait taxonomy. Leif Tibell (1998) urged that robust taxa rest on multiple, independent characters. Pier Luigi Nimis (1998) warned that elevating every apparent clade to genus rank risks "explosive inflation" and listed five tests—monophyly, formal analysis, ≥ 1 diagnostic trait, broad sampling, and demonstrable informational gain—before renaming species. Where those tests are not met, Nimis advised using subgeneric rank so that binomials remain stable. Tibell further separated goals: classification should provide a stable, useful scheme, whereas phylogeny seeks the full branching pattern. He argued that constant renaming for every new tree can undermine nomenclatural stability; revisions should await strong, multi-line evidence. These philosophical perspectives influenced how lichenologists handled emerging molecular results a few years later. By the late 1990s lichenologists, trained in data matrices and synapomorphy logic, were ready to fold DNA data into taxonomy.
The enzyme 2-dehydro-3-deoxy-phosphogluconate aldolase (EC 4.1.2.14), commonly known as KDPG aldolase, catalyzes the chemical reaction 2-dehydro-3-deoxy-D-gluconate 6-phosphate ⇌ {\displaystyle \rightleftharpoons } pyruvate + D-glyceraldehyde 3-phosphate This enzyme belongs to the family of lyases, specifically the aldehyde-lyases, which cleave carbon-carbon bonds. It is used in the Entner–Doudoroff pathway in prokaryotes, feeding into glycolysis. 2-dehydro-3-deoxy-phosphogluconate aldolase is one of the two enzymes distinguishing this pathway from the more commonly known Embden–Meyerhof–Parnas pathway. This enzyme also participates in following 3 metabolic pathways: pentose phosphate pathway, pentose and glucuronate interconversions, and arginine and proline metabolism. In addition to the cleavage of 2-dehydro-3-deoxy-D-gluconate 6-phosphate, it is also found to naturally catalyze Schiff base formation between a lysine ε-amino acid group and carbonyl compounds, decarboxylation of oxaloacetate, and exchange of solvent protons with the methyl hydrogen atoms of pyruvate.
Sodium-22 is a radioactive isotope of sodium, undergoing positron emission to 22Ne with a half-life of 2.6019 years. 22Na is being investigated as an efficient generator of "cold positrons" (antimatter) to produce muons for catalyzing fusion of deuterium. It is also commonly used as a positron source in positron annihilation spectroscopy.
Sources: en.wikipedia.org
It has not been approved as a therapeutic by major regulators, and the human trial record is small and dated. Material available today is mostly sold as a research chemical for laboratory use. Approval and restriction status varies by country.
It binds the ghrelin receptor, known as the growth hormone secretagogue receptor type 1a. Activation of that receptor triggers signaling that leads to growth hormone release. Selectivity for growth hormone over cortisol and prolactin is the property most often cited for this compound.
Published estimates place the circulating half-life at roughly two hours in humans. Clearance involves peptidase activity and renal handling. Because the peptide is short-lived, release patterns after administration are usually described as pulsatile rather than sustained.
Results are most often expressed as a percentage of total peak area from a reversed-phase separation. That figure reflects the detection wavelength, gradient and integration choices used by the laboratory. Two valid certificates can therefore quote different values for the same material without either being incorrect.